Menu
You have to log in or sign up before you can proceed.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

3 Dividend Stocks That Still Make Sense in 2023: https://www.marketbeat.com/logos/articles/med_20230717061732_3-dividend-stocks-that-still-make-sense-in-2023.jpg
3 Dividend Stocks That Still Make Sense in 2023

It was hard to find big stock market winners in 2022. But dividend stocks were among the better performers. Dividend-paying stocks give investors a reward for simply holding on to the stock. That

United Health Stock Is Flying, It May Only Be The Beginning: https://www.marketbeat.com/logos/articles/med_20230714140747_united-health-stock-is-flying-it-may-only-be-the-b.jpg
United Health Stock Is Flying, It May Only Be The Beginning

The United States Economy is beginning to undergo a significant pivot, where specific industries will be rewarded with investment inflows over others. As the FED attempts to combat rampant inflation

United Health Stock Is Flying, It May Only Be The Beginning: https://www.marketbeat.com/logos/articles/med_20230714140747_united-health-stock-is-flying-it-may-only-be-the-b.jpg
United Health Stock Is Flying, It May Only Be The Beginning

The United States Economy is beginning to undergo a significant pivot, where specific industries will be rewarded with investment inflows over others. As the FED attempts to combat rampant inflation

Investors Like Adobe's Potential To Leverage Generative AI: https://www.marketbeat.com/logos/articles/med_20230714053821_investors-like-adobes-potential-to-leverage-genera.jpg
Investors Like Adobe's Potential To Leverage Generative AI

A few decades ago, a comedian named Murray Langston made a splash with an alter ego he dubbed “the unknown comic.” Langson was funny, but nobody knew who he was, since he performed with a bag over

Investors Like Adobe's Potential To Leverage Generative AI: https://www.marketbeat.com/logos/articles/med_20230714053821_investors-like-adobes-potential-to-leverage-genera.jpg
Investors Like Adobe's Potential To Leverage Generative AI

A few decades ago, a comedian named Murray Langston made a splash with an alter ego he dubbed “the unknown comic.” Langson was funny, but nobody knew who he was, since he performed with a bag over

Investors Like Adobe's Potential To Leverage Generative AI: https://www.marketbeat.com/logos/articles/med_20230714053821_investors-like-adobes-potential-to-leverage-genera.jpg
Investors Like Adobe's Potential To Leverage Generative AI

A few decades ago, a comedian named Murray Langston made a splash with an alter ego he dubbed “the unknown comic.” Langson was funny, but nobody knew who he was, since he performed with a bag over

Eilt: 20% der Hautkrebs-Patienten vollständig geheilt - Massives Kaufsignal. Neuer 204% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). : https://www.irw-press.at/prcom/images/messages/2023/71350/AC-170723.001.png
Eilt: 20% der Hautkrebs-Patienten vollständig geheilt - Massives Kaufsignal. Neuer 204% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). : https://www.irw-press.at/prcom/images/messages/2023/71350/AC-170723.001.png
Eilt: 20% der Hautkrebs-Patienten vollständig geheilt - Massives Kaufsignal. Neuer 204% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). : https://www.irw-press.at/prcom/images/messages/2023/71350/AC-170723.001.png
Investing in Blue Chip Stocks: A Guide to Stability and Growth: https://www.marketbeat.com/logos/articles/med_20240716093219_investing-in-blue-chip-stocks-a-guide-to-stability.jpg
Investing in Blue Chip Stocks: A Guide to Stability and Growth

Investors who are looking for stability and steady growth often turn toward blue chip stocks. Blue chip stocks are shares in large, well-established companies with a history of reliable performance

Investing in Blue Chip Stocks: A Guide to Stability and Growth: https://www.marketbeat.com/logos/articles/med_20240716093219_investing-in-blue-chip-stocks-a-guide-to-stability.jpg
Investing in Blue Chip Stocks: A Guide to Stability and Growth

Investors who are looking for stability and steady growth often turn toward blue chip stocks. Blue chip stocks are shares in large, well-established companies with a history of reliable performance

Investing in Blue Chip Stocks: A Guide to Stability and Growth: https://www.marketbeat.com/logos/articles/med_20240716093219_investing-in-blue-chip-stocks-a-guide-to-stability.jpg
Investing in Blue Chip Stocks: A Guide to Stability and Growth

Investors who are looking for stability and steady growth often turn toward blue chip stocks. Blue chip stocks are shares in large, well-established companies with a history of reliable performance

Investing in Blue Chip Stocks: A Guide to Stability and Growth: https://www.marketbeat.com/logos/articles/med_20240716093219_investing-in-blue-chip-stocks-a-guide-to-stability.jpg
Investing in Blue Chip Stocks: A Guide to Stability and Growth

Investors who are looking for stability and steady growth often turn toward blue chip stocks. Blue chip stocks are shares in large, well-established companies with a history of reliable performance

Wells Fargo's Earnings, Why Markets Are Loving The Stock: https://www.marketbeat.com/logos/articles/med_20230714113126_wells-fargos-earnings-why-markets-are-loving-the-s.jpg
Wells Fargo's Earnings, Why Markets Are Loving The Stock

The SPDR S&P 500 ETF Trust (NYSEARCA: SPY) has been trading within a tight channel during the past year, hovering between the $420 and $375 per share marks. This trading range could be seen as

Citigroup Leads Banking Earnings, What's Next?: https://www.marketbeat.com/logos/articles/med_20230714094250_cititechs.jpg
Citigroup Leads Banking Earnings, What's Next?

Not too long ago, commercial and investment banks passed the annual FED 'stress test,' where banks are under the heat of liquidity and leverage scrutiny. The leading United States firms passed

BlackRock Kicks Off Financials Earnings Season, Gauge To Markets: https://www.marketbeat.com/logos/articles/med_20230714091740_blackrock-kicks-off-financials-earnings-season-gau.jpg
BlackRock Kicks Off Financials Earnings Season, Gauge To Markets

A new earnings season is beginning to kick off, bringing on periods of increased volatility and opportunity to investors as long as they position themselves within the favored industries and names

JPMorgan Chase Is In Reversal But Don’t Chase It Higher: https://www.marketbeat.com/logos/articles/med_20230714081700_copy-1-of-chart-jpm-7142023.png
JPMorgan Chase Is In Reversal But Don’t Chase It Higher

The price action in JPMorgan Chase & Company (NYSE: JPM) has been bullish all year. The prospect of higher interest rates, widening margins, and increased earnings have helped to drive the market

JPMorgan Chase Is In Reversal But Don’t Chase It Higher: https://www.marketbeat.com/logos/articles/med_20230714081700_copy-1-of-chart-jpm-7142023.png
JPMorgan Chase Is In Reversal But Don’t Chase It Higher

The price action in JPMorgan Chase & Company (NYSE: JPM) has been bullish all year. The prospect of higher interest rates, widening margins, and increased earnings have helped to drive the market

Fastenal Falls To The Buy Zone: But Wait To Buy More: https://www.marketbeat.com/logos/articles/med_20230714073323_chart-fast-7142023.png
Fastenal Falls To The Buy Zone: But Wait To Buy More

Fastenal (NASDAQ: FAST) fell following its Q2 earnings release and could fall further. The caveat is that tepid results do not overshadow the company’s strengths, including a solid balance sheet

Fastenal Falls To The Buy Zone: But Wait To Buy More: https://www.marketbeat.com/logos/articles/med_20230714073323_chart-fast-7142023.png
Fastenal Falls To The Buy Zone: But Wait To Buy More

Fastenal (NASDAQ: FAST) fell following its Q2 earnings release and could fall further. The caveat is that tepid results do not overshadow the company’s strengths, including a solid balance sheet

Fastenal Falls To The Buy Zone: But Wait To Buy More: https://www.marketbeat.com/logos/articles/med_20230714073323_chart-fast-7142023.png
Fastenal Falls To The Buy Zone: But Wait To Buy More

Fastenal (NASDAQ: FAST) fell following its Q2 earnings release and could fall further. The caveat is that tepid results do not overshadow the company’s strengths, including a solid balance sheet

Broadcom Emerges As Strong Contender For Generative AI Chips: https://www.marketbeat.com/logos/articles/med_20230714055530_broadcom-emerges-as-strong-contender-for-generativ.jpg
Broadcom Emerges As Strong Contender For Generative AI Chips

So far in the AI gold rush, Nvidia Corp. (NASDAQ: NVDA) has emerged as the leading chipmaker. However, analysts and investors are beginning to notice the potential for Broadcom Inc. (NASDAQ: AVGO)

Broadcom Emerges As Strong Contender For Generative AI Chips: https://www.marketbeat.com/logos/articles/med_20230714055530_broadcom-emerges-as-strong-contender-for-generativ.jpg
Broadcom Emerges As Strong Contender For Generative AI Chips

So far in the AI gold rush, Nvidia Corp. (NASDAQ: NVDA) has emerged as the leading chipmaker. However, analysts and investors are beginning to notice the potential for Broadcom Inc. (NASDAQ: AVGO)

Broadcom Emerges As Strong Contender For Generative AI Chips: https://www.marketbeat.com/logos/articles/med_20230714055530_broadcom-emerges-as-strong-contender-for-generativ.jpg
Broadcom Emerges As Strong Contender For Generative AI Chips

So far in the AI gold rush, Nvidia Corp. (NASDAQ: NVDA) has emerged as the leading chipmaker. However, analysts and investors are beginning to notice the potential for Broadcom Inc. (NASDAQ: AVGO)

Deep Value Conagra Brands Pulls Into The Buy Zone: https://www.marketbeat.com/logos/articles/med_20230713123111_chart-cag-7132023.png
Deep Value Conagra Brands Pulls Into The Buy Zone

Conagra Brands (NASDAQ: CAG) isn’t leading the consumer staples sector but is a leading candidate for new investment. The company’s struggles have the share prices trading near multi-year lows and